Clinical Trials
20 trialsNCT04751396 2026-05-20
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
Recruiting
NCT03816345 2026-05-13
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT02808780 2026-05-08
OPAL
Janssen Biotech, Inc.
Active not recruiting
NCT05156125 2026-04-30
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Oppilan Pharma Ltd
Phase 2 Terminated
NCT07223424 2026-04-16
PSI-Immune
University of Pittsburgh
Phase 2 Recruiting
NCT07089771 2026-03-20
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
Region Stockholm
Phase NA Not yet recruiting
NCT04191655 2026-03-06
High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)
Beth Israel Deaconess Medical Center
Phase NA Completed
NCT04806620 2026-01-22
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Recruiting
NCT04767984 2026-01-21
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
Northwestern University
Phase 2 Active not recruiting
NCT07347158 2026-01-16
Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.
Hospital Clinico Universitario de Santiago
Phase NA Enrolling by invitation
NCT07278687 2025-12-12
LATA-IBD
Sahlgrenska University Hospital
Completed
NCT07263464 2025-12-04
The Association Between TNFSF4 Polymorphism and CD
Second Affiliated Hospital of Wenzhou Medical University
Completed
NCT03760003 2025-11-28
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Abivax S.A.
Phase 2 Completed
NCT06881303 2025-11-18
RESTODIG
Assistance Publique Hopitaux De Marseille
Phase NA Not yet recruiting
NCT07046468 2025-08-29
SPIRIT
Radboud University Medical Center
Recruiting
NCT07113717 2025-08-11
POPHaH
Nordsjaellands Hospital
Phase NA Not yet recruiting
NCT04031469 2025-07-31
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
Suspended
NCT06538402 2025-07-09
TESTIMONY
Odense University Hospital
Phase NA Recruiting
NCT05785715 2025-07-01
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
AbbVie
Phase 2 Terminated
NCT05796245 2025-06-04
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer
Completed